High PD-L1 expression (on tumor cells [TC] or tumor-infiltrating immune cells [IC]) correlated with shorter overall survival (OS) and worse prognostic features (high nuclear grade, sarcomatoid differentiation, higher T stage, and poor International Metastatic RCC Database Consortium [IMDC] risk status) [6–9]. The gene discussed is CD274; the disease is renal cell carcinoma.